Swedish Orphan Biovitrum AB (publ)
BIOVF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,407 | $2,954 | $3,321 | $3,295 |
| Dep. & Amort. | $3,679 | $3,200 | $2,419 | $2,006 |
| Deferred Tax | $0 | $0 | -$268 | -$154 |
| Stock-Based Comp. | $0 | $0 | $268 | $154 |
| Change in WC | -$179 | -$1,160 | -$806 | $1,114 |
| Other Non-Cash | -$519 | -$524 | -$269 | -$945 |
| Operating Cash Flow | $7,388 | $4,470 | $4,665 | $5,470 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$170 | -$407 | -$1,477 | -$370 |
| Net Acquisitions | $0 | -$16,961 | $0 | $3 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$2,921 | -$4,536 | -$1,405 | -$320 |
| Investing Cash Flow | -$3,091 | -$21,904 | -$1,477 | -$367 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4,436 | $11,248 | -$2,419 | -$3,998 |
| Stock Issued | $427 | $6,129 | $89 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8 | -$365 | -$572 | -$476 |
| Financing Cash Flow | -$4,001 | $17,012 | -$2,991 | -$4,474 |
| Forex Effect | -$61 | -$35 | $119 | $12 |
| Net Chg. in Cash | $236 | -$457 | $316 | $641 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $904 | $1,361 | $1,045 | $404 |
| End Cash | $1,140 | $904 | $1,361 | $1,045 |
| Free Cash Flow | $4,383 | -$473 | $3,188 | $5,100 |